Delving into the Latest Updates on Mesenchymal Stem Cells(Medical University of South Carolina) with Synapse

Overview

Basic Info

Drug Type

Mesenchymal stem cell therapy

Synonyms-

Target-

Mechanism-

Therapeutic Areas

Immune System DiseasesSkin and Musculoskeletal Diseases

Active Indication

Systemic Lupus Erythematosus

Inactive Indication-

Originator Organization

Medical University of South Carolina

Active Organization

Medical University of South Carolina

Inactive Organization-

Drug Highest PhasePhase 2

First Approval Date-

Regulation-

Login to view timeline

The purpose of this study is to evaluate the efficacy and safety of mesenchymal stem cells (MSCs) obtained from umbilical cords for the treatment of adults with systemic lupus erythematosus (SLE). The goal of this study is to determine if patients receiving an MSC infusion plus standard of care respond better than patients receiving placebo infusion plus standard of care.

Start Date26 Oct 2018

Sponsor / Collaborator

Medical University of South Carolina

NCT03171194 / CompletedPhase 1IIT

A Phase I Safety Trial of Allogeneic Mesenchymal Stem Cells for Systemic Lupus Erythematosus

The purpose of this study is to evaluate the safety of mesenchymal stromal cells (MSCs) obtained from umbilical cords for the treatment of adults with active systemic lupus erythematosus (SLE).

Start Date27 Apr 2017

Sponsor / Collaborator

Medical University of South Carolina

100 Clinical Results associated with Mesenchymal Stem Cells(Medical University of South Carolina)

Login to view more data

100 Translational Medicine associated with Mesenchymal Stem Cells(Medical University of South Carolina)

Login to view more data

100 Patents (Medical) associated with Mesenchymal Stem Cells(Medical University of South Carolina)

Login to view more data

100 Deals associated with Mesenchymal Stem Cells(Medical University of South Carolina)

Login to view more data